Cargando…
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead
Reliable biomarkers for common disorders of gut–brain interaction characterized by abdominal pain, including irritable bowel syndrome (IBS), are critically needed to enhance care and develop individualized therapies. The dynamic and heterogeneous nature of the pathophysiological mechanisms that unde...
Autores principales: | Shin, Andrea, Kashyap, Purna C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072066/ https://www.ncbi.nlm.nih.gov/pubmed/37009874 http://dx.doi.org/10.1080/19490976.2023.2195792 |
Ejemplares similares
-
The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists
por: Chan, Walter W., et al.
Publicado: (2022) -
Disease encumber-What lies ahead??
por: Damle, S. G.
Publicado: (2015) -
Looking back and what lies ahead
por: Chang, David
Publicado: (2022) -
RESEARCH INITIATIVES: What Lies Ahead for Nanotechnology?
por: Stemp-Morlock, Graeme
Publicado: (2009) -
Malaria Eliminating: What Lies Ahead of Iran?
por: Ebrahimzadeh-Leylabadlo, Hamed
Publicado: (2018)